We are live on ! Find out more
EAM

EULAV Asset Management Portfolio holdings

AUM $3.13B
1-Year Est. Return 23.04%
This Fund
S&P 500
This Quarter Est. Return
+3.75%
1 Year Est. Return
+23.04%
3 Year Est. Return
+90.7%
5 Year Est. Return
+115.08%
10 Year Est. Return
+583.23%
AUM
$1.82B
AUM Growth
+$30.8M
Cap. Flow
-$16.1M
Cap. Flow %
-0.88%
Top 10 Hldgs %
13.53%
Holding
298
New
12
Increased
69
Reduced
62
Closed
26

Top Buys

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$11.8M
2
TDG icon
TransDigm Group
TDG
+$4.13M
3
TOL icon
Toll Brothers
TOL
+$3.93M
4
EW icon
Edwards Lifesciences
EW
+$2.98M
5
MKC icon
McCormick & Company Non-Voting
MKC
+$2.6M

Top Sells

Rank Stock Value
1
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$12.8M
2
EQT icon
EQT Corp
EQT
+$9.67M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$7.63M
4
AAPL icon
Apple
AAPL
+$7.06M
5
ARG
Airgas Inc
ARG
+$6.09M

Sector Composition

Rank Sector Weight
1 Industrials 19.95%
2 Healthcare 16.71%
3 Technology 15.77%
4 Consumer Discretionary 15.7%
5 Consumer Staples 8.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KSU
101
DELISTED
Kansas City Southern
KSU
$6.33M 0.35%
70,300
– –
GILD icon
102
Gilead Sciences
GILD
$163B
$6.26M 0.34%
75,000
-41,000
-35% -$3.64M
IHS
103
DELISTED
IHS INC CL-A COM STK
IHS
$6.24M 0.34%
54,000
– –
EL icon
104
Estee Lauder
EL
$30.7B
$6.19M 0.34%
68,000
-3,000
-4% -$280K
FMC icon
105
FMC
FMC
$1.48B
$6.19M 0.34%
154,041
– –
OTEX icon
106
Open Text
OTEX
$6.15B
$6M 0.33%
203,000
+17,200
+9% +$487K
MDT icon
107
Medtronic
MDT
$110B
$5.99M 0.33%
69,000
+1,000
+1% +$80.9K
WWD icon
108
Woodward
WWD
$21.2B
$5.88M 0.32%
102,000
– –
BLK icon
109
Blackrock
BLK
$170B
$5.86M 0.32%
17,100
-900
-5% -$316K
BABA icon
110
Alibaba
BABA
$279B
$5.81M 0.32%
73,000
-4,000
-5% -$313K
JPM icon
111
JPMorgan Chase
JPM
$933B
$5.78M 0.32%
93,000
-21,000
-18% -$1.31M
BKNG icon
112
Booking.com
BKNG
$150B
$5.74M 0.32%
115,000
-15,000
-12% -$779K
ILMN icon
113
Illumina
ILMN
$31B
$5.74M 0.32%
42,045
– –
MNRO icon
114
Monro
MNRO
$421M
$5.71M 0.31%
89,900
+15,000
+20% +$992K
SAM icon
115
Boston Beer
SAM
$1.93B
$5.68M 0.31%
33,232
-2,200
-6% -$356K
TMO icon
116
Thermo Fisher Scientific
TMO
$214B
$5.66M 0.31%
38,300
– –
ICPT
117
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$5.57M 0.31%
39,000
+8,000
+26% +$1.17M
DLTR icon
118
Dollar Tree
DLTR
$24.7B
$5.56M 0.31%
59,000
+20,000
+51% +$1.69M
STZ icon
119
Constellation Brands
STZ
$22.3B
$5.54M 0.3%
33,500
-2,500
-7% -$391K
P
120
DELISTED
Pandora Media Inc
P
$5.54M 0.3%
445,000
-20,000
-4% -$208K
BMRN icon
121
BioMarin Pharmaceuticals
BMRN
$11.7B
$5.52M 0.3%
71,000
– –
XRAY icon
122
Dentsply Sirona
XRAY
$2.75B
$5.51M 0.3%
88,900
+12,000
+16% +$739K
CTSH icon
123
Cognizant
CTSH
$24.3B
$5.5M 0.3%
96,000
-7,000
-7% -$423K
ELS icon
124
Equity Lifestyle Properties
ELS
$12.7B
$5.47M 0.3%
136,800
– –
RNR icon
125
RenaissanceRe
RNR
$13.2B
$5.45M 0.3%
46,400
+4,500
+11% +$516K
3 4
5
6 7

Similar funds

LFG
Larson Financial Group St Louis, Missouri $3.13B AUM 22.88% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.12B AUM 12.93% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CCI
Cevian Capital II St. Helier, Jersey $3.12B AUM 25.62% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
TCG
Tremblant Capital Group West Palm Beach, Florida $3.11B AUM 18.12% 1-Year Est. Return

EULAV Asset Management's Q2 2016 Portfolio in Review

As of Q2 2016, EULAV Asset Management held 298 positions worth $1.82B, up 1.7% from $1.79B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

EULAV Asset Management's Q2 2016 filing shows 12 new, 69 increased, 62 reduced and 26 closed positions. Its largest new stake was Monsanto Co: 25,000 shares worth $2.58M. The largest sale was iShares Russell 2000 Growth ETF, an estimated $12.8M.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Technology.

  • EULAV Asset Management's largest Q2 2016 buy was Monsanto Co: 25,000 shares worth $2.58M.
  • EULAV Asset Management added most to Alexion Pharmaceuticals in Q2 2016, an estimated $11.8M increase.
  • EULAV Asset Management's biggest Q2 2016 reduction was iShares Russell 2000 Growth ETF, cutting an estimated $12.8M.
  • EULAV Asset Management fully exited iShares Russell 2000 ETF in Q2 2016, selling an estimated $7.63M.
  • EULAV Asset Management's ten largest holdings make up 14% of its $1.82B portfolio in Q2 2016.
  • EULAV Asset Management opened 12 new positions and closed 26 in Q2 2016.
  • EULAV Asset Management's portfolio value rose 1.7% quarter-over-quarter to $1.82B.

Based on EULAV Asset Management's 13F filing for Q2 2016, filed 15 Aug 2016.